Home |
Free Dividend Report |
Stock Splits Calendar |
EPRS Historical Stock Prices |
Preferred Stock Newsletter |
EPRS Options Chain |
Stock Message Boards |
EPRS (EPRS) has the following price history information. Looking back at EPRS historical stock prices for the last five trading days, on July 28, 2016, EPRS opened at $0.22, traded as high as $0.26 and as low as $0.15, and closed at $0.15. Trading volume was a total of 9.06M shares. On July 29, 2016, EPRS opened at $0.17, traded as high as $0.17 and as low as $0.13, and closed at $0.14. Trading volume was a total of 4.00M shares. On August 01, 2016, EPRS opened at $0.14, traded as high as $0.22 and as low as $0.14, and closed at $0.17. Trading volume was a total of 8.95M shares. On August 02, 2016, EPRS opened at $0.17, traded as high as $0.18 and as low as $0.14, and closed at $0.15. Trading volume was a total of 4.09M shares. On August 03, 2016, EPRS opened at $0.15, traded as high as $0.15 and as low as $0.14, and closed at $0.14. Trading volume was a total of 2.02M shares.
EPRS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into EPRS shares, starting with a $10,000 purchase of EPRS, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/01/2014 | |
End date: | 08/03/2016 | |
Start price/share: | $12.30 | |
End price/share: | $0.14 | |
Dividends collected/share: | $0.00 | |
Total return: | -98.86% | |
Average Annual Total Return: | -85.20% | |
Starting investment: | $10,000.00 | |
Ending investment: | $113.86 | |
Years: | 2.34 |
EPRS Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
07/28/2016 | $0.22 | $0.26 | $0.15 | $0.15 | 9.06M |
07/29/2016 | $0.17 | $0.17 | $0.13 | $0.14 | 4.00M |
08/01/2016 | $0.14 | $0.22 | $0.14 | $0.17 | 8.95M |
08/02/2016 | $0.17 | $0.18 | $0.14 | $0.15 | 4.09M |
08/03/2016 | $0.15 | $0.15 | $0.14 | $0.14 | 2.02M |
About EPRS |
EPIRUS Biopharmaceuticals is a biopharmaceutical company engaged in developing, manufacturing, and commercializing biosimilar therapeutics (biosimilars). Co.'s primary product candidate is BOW015, a biosimilar version of Remicade®. Remicade is marketed by Johnson & Johnson, Merck Schering and Mitsubishi Tanabe for the treatment of various inflammatory diseases. Co.'s biosimilar product candidates also includes BOW050, a biosimilar version of Humira®, which is marketed by AbbVie and used to treat inflammatory diseases, and BOW070, a biosimilar version of Actemra®, which is marketed by Genentech/Roche and used to treat inflammatory diseases. BOW050 and BOW070 are in preclinical development. |
EPRS Historical Closing Prices | |
Date | Close |
07/28/2016 | $0.15 |
07/29/2016 | $0.14 |
08/01/2016 | $0.17 |
08/02/2016 | $0.15 |
08/03/2016 | $0.14 |
Healthcare Historical Prices |
EPRS is categorized under the Healthcare sector; below are some other companies in the same sector:
EPZM Historical Stock Prices
Free EPRS Email Alerts:
|
EPRS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.